Table 3 Treatment responses on day 28
Total | Age | Residence | ||||
|---|---|---|---|---|---|---|
≤ 5 yrs old | > 5 yrs old | Urban area | Suburban area | |||
Number of patients: N | 197 | 96 | 101 | 125 | 72 | |
PCR uncorrected responses on day 28 | Withdrawn + Lost-to-follow-up, N (%) | 15 (7.6) | 10 (10.4) | 5 (5) | 11 (8.8) | 4 (8.1) |
Eligible; N (%) | 182 (92.4) | 86 (89.6) | 96 (95) | 114 (91.2) | 68 (91.9) | |
Failure; N (%) | 31 (17) | 20 (23.3) | 11 (11.5) | 18 (15.8) | 13 (19.1) | |
ETF; N (%) | 1 (0.5) | 0 | 1 (1) | 1 (0.9) | 0 | |
LCF; N (%) | 14 (7.7) | 10 (11.2) | 4 (4.2) | 9 (7.9) | 5 (7.4) | |
LPF; N (%) | 16 (8.8) | 10 (11.2) | 6. (6.3) | 8 (7) | 8 (11.8) | |
ACPR; N (%) | 151 (83) | 66 (76.7) | 85 (88.5) | 96 (84.2) | 55 (80.9) | |
PCR corrected responses on day 28 | Withdrawn + Lost-to-follow-up + reinfection + not analyzed; N (%) | 37 (18.8) | 26 (27.1) | 11 (10.9) | 24 (19.2) | 13 (18.1) |
Eligible; N (%) | 160 (81.2) | 70 (72.9) | 90 (89.1) | 101 (80.8) | 59 (81.9) | |
Failure; N (%) | 9 (5.6) | 4 (5.7) | 5 (5.6) | 5 (5) | 4 (6.8) | |
ETF; N (%) | 1 (0.6) | 0 | 1 (1.1) | 1 (1) | 0 | |
Recrudescence; N (%) | 8 (5) | 4 (5.7) | 4 (4.5) | 4 (4) | 4 (6.8) | |
ACPR; N (%) | 151 (94.4) | 66 (94.3) | 85 (94.4) | 96 (95) | 55 (93.2) | |
Recrudescence; N | 8 | 4 | 4 | 4 | 4 | |
Reinfection; N | 10 | 7 | 3 | 3 | 7 | |